RHBDF2 and gastric cancer: revealed that IL-1α, in addition to other inflammatory cytokines, induced the transformation of non-cancerous fibroblasts into CAFs by activating RHBDF2/TGFβ signaling and enhancing CAF motility, thereby stimulating diffuse-type gastric cancer cells to invade the ECM and lymphatic vessels [44].